Profile
Sector:
HealthcareCountry:
United StatesIPO:
10 February 2006Website:
http://www.acorda.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Thu, 13 Jun 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
ACOR Latest News
Shares of Acorda Therapeutics ACOR, +1.96% fell late Monday after the company said it had filed for bankruptcy protection.
Acorda Therapeutics, Inc. (NASDAQ:ACOR ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Tierney Saccavino - EVP, Corporate Communications Ron Cohen - Founder, CEO, President & Director Michael Gesser - CFO Conference Call Participants Operator Welcome to Acorda Therapeutics Third Quarter 2023 Financial and Business Update. At this time, all participants are in a listen-only mode.
Prudent investors are now forced to reassess their portfolios and risk profiles. Indeed, for those invested in penny stocks, the promise of substantial returns is great.
What type of business is Acorda Therapeutics?
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.
What sector is Acorda Therapeutics in?
Acorda Therapeutics is in the Healthcare sector
What industry is Acorda Therapeutics in?
Acorda Therapeutics is in the Drug Manufacturers - Specialty & Generic industry
What country is Acorda Therapeutics from?
Acorda Therapeutics is headquartered in United States
When did Acorda Therapeutics go public?
Acorda Therapeutics initial public offering (IPO) was on 10 February 2006
What is Acorda Therapeutics website?
https://www.acorda.com
Is Acorda Therapeutics in the S&P 500?
No, Acorda Therapeutics is not included in the S&P 500 index
Is Acorda Therapeutics in the NASDAQ 100?
No, Acorda Therapeutics is not included in the NASDAQ 100 index
Is Acorda Therapeutics in the Dow Jones?
No, Acorda Therapeutics is not included in the Dow Jones index
When does Acorda Therapeutics report earnings?
Next earnings report date is not announced yet